Practical guidance for documenting condition status, assessment, treatment, and follow-up during AWVs.
10/05/26
What providers need to know about submitting records for RADV review.
10/05/26
HCPCS codes and products affected by the November authorization change.
10/05/26
Key topics to address during AWVs to support HOS outcomes.
10/05/26
Screening tools, follow-up requirements, exclusions, and MY2027 preparation.
10/05/26
Eligibility, exclusion criteria, and example ICD-10 codes for the SPC measure.
10/05/26
Required elements for documenting telephone follow-up after an ED visit.
10/05/26
What to record for screenings, hysterectomy exclusions, and outside results.
10/05/26
Guidance on eligible generic prescriptions, retail access, and mail-order requirements.
10/05/26
Formulary considerations, pharmacy coordination, and patient discussion points for biosimilars.
10/05/26